Bulletin
Investor Alert

New York Markets Close in:

Gilead Sciences Inc.

NAS: GILD

GO
/marketstate/country/us

Market open

 --Real time quotes

Mar 21, 2023, 12:50 p.m.

/zigman2/quotes/210293917/composite

$

78.73

Change

-0.73 -0.92%

Volume

Volume 1.93m

Real time quotes

/zigman2/quotes/210293917/composite

Previous close

$ 79.46

$ 78.73

Change

-0.73 -0.92%

Day low

Day high

$78.73

$80.05

Open

52 week low

52 week high

$57.17

$89.74

Open

Insider Actions for Gilead Sciences Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/01/2023 Daniel P. O'Day
Chairman & CEO; Director
4,842   Derivative/Non-derivative trans. at $79.59 per share. 385,374
03/01/2023 Merdad V. Parsey
Chief Medical Officer
12,984   Disposition at $79.96 per share. 1,038,200
03/01/2023 Daniel P. O'Day
Chairman & CEO; Director
11,362   Derivative/Non-derivative trans. at $0 per share. 0
02/15/2023 Andrew D. Dickinson
Chief Financial Officer
376   Award at $56.38 per share. 21,198
02/15/2023 Merdad V. Parsey
Chief Medical Officer
376   Award at $56.38 per share. 21,198
02/15/2023 Deborah H. Telman
EVP, Corporate Affairs & GC
376   Award at $56.38 per share. 21,198
02/06/2023 Andrew D. Dickinson
Chief Financial Officer
531   Derivative/Non-derivative trans. at $86.36 per share. 45,857
02/06/2023 Diane E. Wilfong
SVP, Controller & CAO
565   Derivative/Non-derivative trans. at $86.36 per share. 48,793
02/06/2023 Andrew D. Dickinson
Chief Financial Officer
1,817   Derivative/Non-derivative trans. at $0 per share. 0
02/06/2023 Diane E. Wilfong
SVP, Controller & CAO
1,864   Derivative/Non-derivative trans. at $0 per share. 0
01/24/2023 Daniel P. O'Day
Chairman & CEO; Director
59,078   Derivative/Non-derivative trans. at $84.02 per share. 4,963,733
01/24/2023 Andrew D. Dickinson
Chief Financial Officer
15,327   Derivative/Non-derivative trans. at $84.02 per share. 1,287,774
01/24/2023 Johanna Mercier
Chief Commercial Officer
15,325   Derivative/Non-derivative trans. at $84.02 per share. 1,287,606
01/24/2023 Merdad V. Parsey
Chief Medical Officer
17,749   Derivative/Non-derivative trans. at $84.02 per share. 1,491,270
01/24/2023 Diane E. Wilfong
SVP, Controller & CAO
1,244   Derivative/Non-derivative trans. at $84.02 per share. 104,520
01/24/2023 Daniel P. O'Day
Chairman & CEO; Director
136,647   Award at $0 per share. 0
01/24/2023 Daniel P. O'Day
Chairman & CEO; Director
78,370   Award at $0 per share. 0
01/24/2023 Andrew D. Dickinson
Chief Financial Officer
38,270   Award at $0 per share. 0
01/24/2023 Andrew D. Dickinson
Chief Financial Officer
27,932   Award at $0 per share. 0
01/24/2023 Johanna Mercier
Chief Commercial Officer
38,270   Award at $0 per share. 0
01/24/2023 Johanna Mercier
Chief Commercial Officer
29,124   Award at $0 per share. 0
01/24/2023 Merdad V. Parsey
Chief Medical Officer
43,715   Award at $0 per share. 0
01/24/2023 Merdad V. Parsey
Chief Medical Officer
29,644   Award at $0 per share. 0
01/24/2023 Diane E. Wilfong
SVP, Controller & CAO
4,100   Award at $0 per share. 0
01/24/2023 Diane E. Wilfong
SVP, Controller & CAO
1,784   Award at $0 per share. 0
12/30/2022 Merdad V. Parsey
Chief Medical Officer
553   Disposition at $85.33 per share. 47,187
12/10/2022 Daniel P. O'Day
Chairman & CEO; Director
1,542   Derivative/Non-derivative trans. at $87.97 per share. 135,649
12/10/2022 Andrew D. Dickinson
Chief Financial Officer
480   Derivative/Non-derivative trans. at $87.97 per share. 42,225
12/10/2022 Johanna Mercier
Chief Commercial Officer
463   Derivative/Non-derivative trans. at $87.97 per share. 40,730
12/10/2022 Merdad V. Parsey
Chief Medical Officer
486   Derivative/Non-derivative trans. at $87.97 per share. 42,753
12/10/2022 Diane E. Wilfong
SVP, Controller & CAO
149   Derivative/Non-derivative trans. at $87.97 per share. 13,107
12/10/2022 Daniel P. O'Day
Chairman & CEO; Director
3,300   Derivative/Non-derivative trans. at $0 per share. 0
12/10/2022 Andrew D. Dickinson
Chief Financial Officer
1,027   Derivative/Non-derivative trans. at $0 per share. 0
12/10/2022 Johanna Mercier
Chief Commercial Officer
990   Derivative/Non-derivative trans. at $0 per share. 0
12/10/2022 Merdad V. Parsey
Chief Medical Officer
1,039   Derivative/Non-derivative trans. at $0 per share. 0
12/10/2022 Diane E. Wilfong
SVP, Controller & CAO
318   Derivative/Non-derivative trans. at $0 per share. 0
11/10/2022 Andrew D. Dickinson
Chief Financial Officer
851   Derivative/Non-derivative trans. at $82.6 per share. 70,292
11/10/2022 Merdad V. Parsey
Chief Medical Officer
2,268   Derivative/Non-derivative trans. at $82.6 per share. 187,336
11/10/2022 Andrew D. Dickinson
Chief Financial Officer
1,912   Derivative/Non-derivative trans. at $0 per share. 0
11/10/2022 Merdad V. Parsey
Chief Medical Officer
5,099   Derivative/Non-derivative trans. at $0 per share. 0
11/09/2022 Diane E. Wilfong
SVP, Controller & CAO
6,416   Disposition at $83.5 per share. 535,736
11/09/2022 Diane E. Wilfong
SVP, Controller & CAO
6,416   Derivative/Non-derivative trans. at $63.91 per share. 410,046
11/01/2022 Diane E. Wilfong
SVP, Controller & CAO
16,255   Disposition at $79.25 per share. 1,288,208
11/01/2022 Diane E. Wilfong
SVP, Controller & CAO
16,255   Derivative/Non-derivative trans. at $72.7 per share. 1,181,738
09/10/2022 Daniel P. O'Day
Chairman & CEO; Director
1,528   Derivative/Non-derivative trans. at $65.28 per share. 99,747
09/10/2022 Andrew D. Dickinson
Chief Financial Officer
476   Derivative/Non-derivative trans. at $65.28 per share. 31,073
09/10/2022 Johanna Mercier
Chief Commercial Officer
458   Derivative/Non-derivative trans. at $65.28 per share. 29,898
09/10/2022 Merdad V. Parsey
Chief Medical Officer
481   Derivative/Non-derivative trans. at $65.28 per share. 31,399
09/10/2022 Diane E. Wilfong
SVP, Controller & CAO
148   Derivative/Non-derivative trans. at $65.28 per share. 9,661
09/10/2022 Daniel P. O'Day
Chairman & CEO; Director
3,301   Derivative/Non-derivative trans. at $0 per share. 0
09/10/2022 Andrew D. Dickinson
Chief Financial Officer
1,027   Derivative/Non-derivative trans. at $0 per share. 0
09/10/2022 Johanna Mercier
Chief Commercial Officer
990   Derivative/Non-derivative trans. at $0 per share. 0
09/10/2022 Merdad V. Parsey
Chief Medical Officer
1,039   Derivative/Non-derivative trans. at $0 per share. 0
09/10/2022 Diane E. Wilfong
SVP, Controller & CAO
318   Derivative/Non-derivative trans. at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
16 Purchases
10 Sales
444,027
128,198
Last 6 months
25 Purchases
19 Sales
480,383
157,108
Last 12 months
53 Purchases
34 Sales
553,578
170,180

Officers and Executives

Mr. Daniel P. O'Day
Chairman & Chief Executive Officer
Mr. Andrew D. Dickinson
Chief Financial Officer
Dr. Merdad V. Parsey
Chief Medical Officer
Dr. Flavius Martin
Executive Vice President-Research
Ms. Johanna Mercier
Chief Commercial Officer
Dr. Tomas Cihlar
Vice President-Virology
Dr. Linda Slanec Higgins
Senior VP-Research & External Innovation
Dr. Mark Genovese
Senior Vice President-Inflammation Development
Ms. Janet Dorling
Senior VP-Global Commercial Product Strategy
Dr. William Grossman
Senior VP-Oncology Clinical Development
Dr. Adam Levy
Executive Director-Investor Relations
Mr. Dustin Haines
Vice President & General Manager-Asia 5
Mr. Joydeep Ganguly
Senior Vice President-Corporate Operations
Dr. Stacey Y. Ma
EVP-Pharmaceutical Development & Manufacturing
Ms. Melissa Grigorieff Koomey
Vice President-Global Commercial Operations
Ms. Sandra K. Patterson
SVP, Chief Accounting Officer & Controller
Ms. Jacquie Ross
Head-Investor Relations
Ms. Jyoti K. Mehra
Executive Vice President-Human Resources
Ms. Deborah H. Telman
Secretary, EVP-Corporate Affairs & General Counsel
Dr. Sandra J. Horning
Independent Director
Mr. Javier J. Rodriguez
Independent Director
Mr. Anthony Welters
Independent Director
Dr. Jeffrey A. Bluestone
Independent Director
Mr. Kevin E. Lofton
Lead Independent Director
Ms. Kelly A. Kramer
Independent Director
Dr. Jacqueline K. Barton
Independent Director
Mr. Harish M. Manwani
Independent Director
Link to MarketWatch's Slice.